MYOS RENS Technology Inc (MYOS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MYOS RENS Technology Inc (MYOS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8062
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MYOS RENS Technology Inc (MYOS RENS), formerly MYOS Corp is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken egg yolk that is processed using a patented technology which preserves its biological integrity and bioactivity for increase of muscle size and lean body mass in conjunction with resistance training. MYOS RENS’s biotherapeutics research and development activities are concentrated on medical health, nutrition, consumer health and animal health. It also undertakes human clinical trials and pre-clinical studies for the treatment of various diseases such as sarcopenia, cachexia and degenerative muscle disease. The company partners with other institutions for its research and development activities. MYOS RENS is headquartered in Cedar Knolls, New Jersey, the US.

MYOS RENS Technology Inc (MYOS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Atlas Therapeutics Raises US$0.73 Million In Venture Financing 10
Partnerships 11
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 11
Myos Enters into R&D Agreement with Cloud Pharma 12
Myos Enters Into Co-Marketing Agreement With Maximum Human Performance For MYO-T12 13
Equity Offering 14
MYOS RENS Technology Plans to Raise USD75 Million in Public Offering 14
MYOS RENS Technology to Raise up to USD6 Million in Public Offering of Shares 15
MYOS RENS Raises USD2 Million in Private Placement of Shares 16
Myos Raises USD5.2 Million in First Tranche of Private Placement of Shares and Warrants 17
Myos Raises USD1.8 Million in Private Placement of Shares 18
Myos Completes Private Placement Of Units For US$4.7 Million 20
Myos Completes Private Placement Of Shares For US$5.6 Million 21
MYOS Raises USD0.6 Million in Private Placement of Shares 22
MYOS Raises USD0.1 Million in Private Placement of Shares 23
MYOS Raises USD1 Million in Private Placement of Shares 24
Debt Offering 25
MYOS Raises USD0.6 Million in Private Placement of Notes 25
MYOS RENS Technology Inc – Key Competitors 26
MYOS RENS Technology Inc – Key Employees 27
MYOS RENS Technology Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Aug 08, 2018: MYOS RENS Technology reports 49% increase in net revenues in second quarter of 2018 29
May 09, 2018: MYOS RENS Technology Reports First Quarter Financial Results 31
Mar 27, 2018: MYOS RENS Technology Reports Fourth Quarter And Fiscal 2017 Financial Results 33
Nov 14, 2017: MYOS RENS Technology Reports Third Quarter 2017 Financial Results 35
Corporate Communications 36
Sep 20, 2017: MYOS RENS Technology Appoints Joseph Mannello as Permanent Chief Executive Officer 36
Other Significant Developments 37
Mar 28, 2018: MYOS RENS Technology CEO Joseph Mannello Provides Comments On Operational And Financial Results For Fiscal Year 2017 37
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYOS RENS Technology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Atlas Therapeutics Raises US$0.73 Million In Venture Financing 10
MYOS RENS Technology Enters into Research Agreement with University Of California Berkley 11
Myos Enters into R&D Agreement with Cloud Pharma 12
Myos Enters Into Co-Marketing Agreement With Maximum Human Performance For MYO-T12 13
MYOS RENS Technology Plans to Raise USD75 Million in Public Offering 14
MYOS RENS Technology to Raise up to USD6 Million in Public Offering of Shares 15
MYOS RENS Raises USD2 Million in Private Placement of Shares 16
Myos Raises USD5.2 Million in First Tranche of Private Placement of Shares and Warrants 17
Myos Raises USD1.8 Million in Private Placement of Shares 18
Myos Completes Private Placement Of Units For US$4.7 Million 20
Myos Completes Private Placement Of Shares For US$5.6 Million 21
MYOS Raises USD0.6 Million in Private Placement of Shares 22
MYOS Raises USD0.1 Million in Private Placement of Shares 23
MYOS Raises USD1 Million in Private Placement of Shares 24
MYOS Raises USD0.6 Million in Private Placement of Notes 25
MYOS RENS Technology Inc, Key Competitors 26
MYOS RENS Technology Inc, Key Employees 27
MYOS RENS Technology Inc, Subsidiaries 28

List of Figures
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MYOS RENS Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MYOS RENS Technology Inc (MYOS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MEAG Munich Ergo AssetManagement GmbH:電力:M&Aディール及び事業提携情報
    Summary MEAG Munich Ergo AssetManagement GmbH (MEAG Munich), a subsidiary of Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft (Munich Re) is an asset management company that manages assets of Munich Re and ERGO Insurance Group and its affiliates. The company offers services such as asset …
  • Boule Diagnostics AB (BOUL):医療機器:M&Aディール及び事業提携情報
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • Setpoint Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary SetPoint Medical Inc (SetPoint Medical) is a clinical-stage biomedical technology company that develops bioelectronic therapies for the treatment of inflammatory autoimmune diseases. The company develops a new bioelectronic medicine platform, which induces the vagus nerve to activate the bod …
  • KEPCO Plant Service & Engineering Co Ltd (051600):企業の財務・戦略的SWOT分析
    KEPCO Plant Service & Engineering Co Ltd (051600) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Postnl N.V.:企業の戦略・SWOT・財務分析
    Postnl N.V. - Strategy, SWOT and Corporate Finance Report Summary Postnl N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Velvet Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Velvet Energy Ltd (Velvet Energy) is an oil and gas exploration company that explores and develops oil and liquid-rich natural gas from its assets. The company’s exploration and development operation assets are located in Deep Basin in West-Central Alberta. It produces 17,000 barrels of oil …
  • Nichirei Corp (2871):企業の財務・戦略的SWOT分析
    Nichirei Corp (2871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hudson Global Inc (HSON):企業の財務・戦略的SWOT分析
    Hudson Global Inc (HSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Elanix Biotechnologies AG (ELN):製薬・医療:M&Aディール及び事業提携情報
    Summary Elanix Biotechnologies AG (Elanix Biotechnologies), formerly Porta Systems AG, is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological and gynecological applications. The company offers GYNrepair cream and SKINrepair cream for skin care …
  • AB Volvo:企業の戦略・SWOT・財務情報
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Reliance Industries Ltd (RELIANCE):石油・ガス:M&Aディール及び事業提携情報
    Summary Reliance Industries Ltd (RIL) is a conglomerate with business interests in energy, petrochemicals, textiles, retail, and telecommunication sectors. The company carries out exploration, development and production of oil and gas, refining of crude oil, marketing of petroleum products, and prod …
  • Valeo S.A.:企業の戦略・SWOT・財務分析
    Valeo S.A. - Strategy, SWOT and Corporate Finance Report Summary Valeo S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Episurf Medical AB (EPIS B):企業の製品パイプライン分析2018
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, E …
  • National Grid Plc (NG):電力:M&Aディール及び事業提携情報
    Summary National Grid Plc (National Grid) is an energy utility. It transmits and distributes electricity and gas. The company owns and operates electricity and gas transmission and distribution networks; and is also the system operator for the Scottish networks. National Grid provides installation a …
  • Wacoal Holdings Corp (3591):企業の財務・戦略的SWOT分析
    Wacoal Holdings Corp (3591) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • FLYHT Aerospace Solutions Ltd.:企業の戦略・SWOT・財務分析
    FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Unilever Ghana Ltd.:企業の戦略・SWOT・財務分析
    Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report Summary Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Samsung Biologics Co Ltd (207940):製薬・医療:M&Aディール及び事業提携情報
    Summary Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The company’s business activities include process development, contract manufacturing, aseptic fill and finish and project management. Samsung Biologics cell culture development process include …
  • Esprit Holdings Limited:企業の戦略・SWOT・財務分析
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BOE Technology Group Co Ltd:戦略・SWOT・企業財務分析
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆